- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-20-0079152

Torrey Pharmaceuticals Private Limited
About Torrey Pharmaceuticals Private Limited
Data last updated:
Torrey Pharmaceuticals Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the artificial fibres segment of the food and beverages sector. It was incorporated on 07 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U24304MH2016PTC288263.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shivangi Singh and Shalini Chaurasia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No.16 Shiv Arcade Bhilgaon, Nagpur, Maharashtra, India – 441002.
As per the financials filed for FY 2024, the company reported a revenue of ₹42.92 Lakh, a growth of 116% compared to the previous year. For the same year it recorded a net profit of ₹69,221 (net margin 1.6%) and EBITDA of ₹93,811 (EBITDA margin 2.2%). Revenue has grown at a compounded annual rate (CAGR) of 249% over three years and 135% over five years.
Torrey Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-20-0079152). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Torrey Pharmaceuticals
Contact details
Torrey Pharmaceuticals Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No.16 Shiv Arcade Bhilgaon, Nagpur, Maharashtra, India – 441002
- IndustryFood And Beverages, Artificial Fibres, Manufacturing
To see the full contact details of Torrey Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Torrey Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Torrey Pharmaceuticals Private Limited, buy the company report.
Financials of Torrey Pharmaceuticals Private Limited
FY 2025 filings availableTorrey Pharmaceuticals Private Limited reported revenue of ₹42.92 Lakh (up 116% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 135% over five years, including 116% growth in the latest year. EBITDA rose 94% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹93,811 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹69,221 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.2% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Torrey Pharmaceuticals Private Limited, buy the company report.
Board of directors of Torrey Pharmaceuticals Private Limited
Torrey Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shivangi Singh | Director | 18 Jan 2019 | 7 Years 10 Months | Current |
| Shalini Chaurasia | Director | 22 Jun 2018 | 8 Years 5 Months | Current |
Peer comparison
Torrey Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Amare Cor Pharmaceuticals Private Limited | ₹43.06 Lakh (FY 2024) | -4.0% | Ranchi, Jharkhand, India | |||
| SMV Pharmaceuticals Private Limited | ₹42.95 Lakh (FY 2025) | 2.0% | Chandigarh, India | |||
| Arlics Pharmaceuticals Private Limited | ₹42.92 Lakh (FY 2025) | 1.0% | Mehsana, Gujarat, India | |||
| Torrey Pharmaceuticals Private Limitedthis company | ₹42.92 Lakh (FY 2024) | ₹69,221 | 1.6% | 116.0% | Nagpur, Maharashtra, India | |
| Denexo Pharmaceuticals Private Limited | ₹42.9 Lakh (FY 2025) | 4.0% | Kharghar, Maharashtra, India | |||
| Trumedis Pharmaceuticals Private Limited | ₹42.85 Lakh (FY 2025) | 0.0% | New Delhi, Delhi, India | |||
| Wevet Pharmaceuticals Private Limited | ₹42.84 Lakh (FY 2024) | 69.0% | Allahabad, Uttar Pradesh, India |
To see the full peer comparison of Torrey Pharmaceuticals Private Limited, buy the company report.
Auditor
Torrey Pharmaceuticals Private Limited is audited by ACHAL SRIVASTAVA & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ACHAL SRIVASTAVA & CO. | FY 2017 | 013385C |
Shareholding
The shareholding of Torrey Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Torrey Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Torrey Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Torrey Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Torrey Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Torrey Pharmaceuticals Private Limited has 7 board changes on record since 2018: 2 appointments and 5 cessations. The latest: Sajal Mani Tripathi ceased to be Director on 26 Nov 2019.
Frequently asked questions
Torrey Pharmaceuticals is an active private limited company based in Nagpur, Maharashtra, India. The company works in artificial fibres, within the food and beverages industry. It was incorporated on 07 December 2016 (10+ years old) and is registered under CIN U24304MH2016PTC288263.
Torrey Pharmaceuticals has 2 current directors:
- Shivangi Singh - Director
- Shalini Chaurasia - Director
The latest financial statements of Torrey Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The CIN (Corporate Identification Number) of Torrey Pharmaceuticals is U24304MH2016PTC288263. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Torrey Pharmaceuticals was incorporated on 07 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Nagpur.
The peers of Torrey Pharmaceuticals by revenue are Amare Cor Pharmaceuticals Private Limited, SMV Pharmaceuticals Private Limited, Arlics Pharmaceuticals Private Limited, Denexo Pharmaceuticals Private Limited, Trumedis Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Sajal Mani Tripathi ceased to be Director on 26 Nov 2019. Shalini Chaurasia ceased to be Additional Director on 30 Sep 2019. Shivangi Singh ceased to be Additional Director on 30 Sep 2019. Torrey Pharmaceuticals has 7 board changes on record in total.
Yes, Torrey Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-20-0079152).
The registered office of Torrey Pharmaceuticals is at House No.16 Shiv Arcade Bhilgaon, Nagpur, Maharashtra, India – 441002.
Torrey Pharmaceuticals operates in the food and beverages industry, in the artificial fibres segment.
The compliance status of Torrey Pharmaceuticals is compliant as of 04 July 2026. The company is actively filing with the Registrar of Companies.

